Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mingshui Fukang Chemical is a Chinese pharmaceutical and chemical manufacturing company focused on chiral amines and phosphonate-related intermediates used in drug manufacturing. The company appears to operate primarily as a commercial supplier of pharmaceutical chemical intermediates rather than as a therapeutic drug developer. Its product portfolio includes intermediates associated with fosfomycin sodium production as well as phenylethylamine derivatives used in pharmaceutical chemistry. Available public information indicates that the business serves as an upstream manufacturing and supply partner to Chinese pharmaceutical producers, including entities associated with Harbin Pharmaceutical Group. For biotech and pharma diligence purposes, it is best characterized as a small-molecule pharmaceutical intermediate manufacturer with manufacturing operations in Heilongjiang, China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fukang Chemical.